Anti-rubella IgG serum levels predict risk for SARS-CoV-2 breakthrough
infections
- Moritz M. Hollstein,
- Sascha Dierks,
- Michael Schön,
- Uwe Groß,
- Karin Thiele,
- Andreas Leha,
- Andreas E. Zautner,
- Andreas Fischer,
- Luise Erpenbeck,
- Moritz Schnelle
20 May 2024Submitted to Allergy 08 Jun 2024Review(s) Completed, Editorial Evaluation Pending
10 Jun 2024Editorial Decision: Revise Minor
16 Jun 20241st Revision Received
20 Jun 2024Reviewer(s) Assigned
24 Jun 2024Review(s) Completed, Editorial Evaluation Pending
28 Jun 2024Editorial Decision: Accept
